Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma IncfiledCriticalAventis Pharma Inc
Priority to ARP010102082ApriorityCriticalpatent/AR032881A1/en
Publication of AR032881A1publicationCriticalpatent/AR032881A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describe y reivindica un paquete para dispensar dos o más compuestos farmacéuticamente activos. En una de las reivindicaciones de esta invencion, el paquete dispensa esencialmente: a) un recipiente 1 para dispensar fármaco A, que tiene cantidades terapéuticamente efectivas de fexofenadina o de su sal de adicion farmacéuticamente aceptable, y b) un recipiente 2 para dispensar fármaco B, que contiene cantidades terapéuticamente efectivas de una combinacion de fexofenadina y pseudoefedrina o sus sales de adicion farmacéuticamente aceptables. En esta realizacion, se proporciona también una indicacion para distinguir entre los fármacos A y B en los recipientes 1 y 2. También se describen y reivindican diversas realizaciones preferidas del paquete de esta invencion.A package for dispensing two or more pharmaceutically active compounds is described and claimed. In one of the claims of this invention, the package essentially dispenses: a) a container 1 for dispensing drug A, which has therapeutically effective amounts of fexofenadine or its pharmaceutically acceptable addition salt, and b) a container 2 for dispensing drug B, containing therapeutically effective amounts of a combination of fexofenadine and pseudoephedrine or their pharmaceutically acceptable addition salts. In this embodiment, an indication is also provided to distinguish between drugs A and B in containers 1 and 2. Various preferred embodiments of the package of this invention are also described and claimed.
ARP010102082A2001-05-032001-05-03
PACKING REGIME OF PSEUDOEFEDRINE CHLORHYDRATE AND PHEXOPHENADINE CHLORHYDRATE
AR032881A1
(en)
PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
PHARMACEUTICAL SALTS OF THE ACTIVE SUBSTANCE TRAMADOL AND AT LEAST ONE SWEETENER, MEDICINES CONTAINING THESE SALTS, THE USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES AND FORMS OF ADMINISTRATION CONTAINING THOSE SALTS. LAW 17164
USE OF DIRECT OR INDIRECT SELECTIVE INHIBITORS OF FACTOR XA ALONE OR IN COMBINATION WITH AN ANTI-AGGREGATE PLATELET COMPOUND AND COMPOSITIONS INTENDED TO PREVENT AND TREAT ARTERIAL THROMBOEMBOLIC DISEASES
USE OF 1- (2-NAFT-2-ILETIL) -4- (3-TRIFLUOROMETILFENIL) -1,2,3,6-TETRAHYDROPIRIDINE FOR THE PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF AMIOTROPHIC SIDE SCLEROSIS.
THE PSEUDOPOLIMORPHIC FORM OF (+/-) 1- (4-CARBAZOLILOXI) -3- [2- (2-METOXIFENOXI) ETHYLAMINE] -2-PROPANOL OR OPTICALLY ACTIVE OR SALES PHARMACEUTICALLY ACCEPTABLE OF THE SAME, USE OF THE SAME, A PHARMACEUTICALLY ACCEPTABLE COMPOSITION THAT UNDERSTANDS IT, A FORM OF ADMINISTRATION FARMACEUTICAME